Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Dermatology Reports|March 18, 2025
Cutting-edge insights: LC-OCT and 5% cyclosporine for early lichen sclerosus treatmentCaterina Mariarosaria Giorgio, Vittorio Tancredi, Gaetano Licata, et al.Dermatology Practical & Conceptual|December 19, 2022
Adiponectin Contributes to the Inflammatory Milieu in Hidradenitis SuppurativaErsilia Nigro, Rita Polito, Graziella Babino, et al.Journal of the American Academy of Dermatology|July 12, 2020
Melanoma diagnosed on digital dermoscopy monitoring: A side-by-side image comparison is needed to improve early detectionGraziella Babino, Aimilios Lallas, Marina Agozzino, et al.Dermatology Reports|April 11, 2025
Facial skin rejuvenation through plasma radiofrequency ablation combined with 5% resorcinol cream: clinical and LC-OCT evaluationCaterina Mariarosaria Giorgio, Gaetano Licata, Eugenia Veronica Di Brizzi, et al.Italian Journal of Dermatology and Venereology|October 3, 2025
Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter studyMichela Starace, Stephano Cedirian, Luca Rapparini, et al.The Journal of Dermatological Treatment|January 6, 2025
Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world studyCarlo A Vignoli, Luigi Gargiulo, Luciano Ibba, et al.Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|October 4, 2019
Italian Guidelines in diagnosis and treatment of alopecia areataAlfredo Rossi, Marta Muscianese, Bianca M Piraccini, et al.Italian Journal of Dermatology and Venereology|May 29, 2024
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patientsBianca Maria Piraccini, Luca Rapparini, Federico Quadrelli, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2025
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week resultsBianca Maria Piraccini, Stephano Cedirian, Francesca Pampaloni, et al.American Journal of Clinical Dermatology|March 19, 2026
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World StudyMichela Starace, Luca Rapparini, Francesca Pampaloni, et al.Pageof 2